Our commitment to action: Burnet Disability Plan
Establishing a clinical trial for novel therapies to address long COVID
Celebrating the 2024 Burnet Travel Awards
Dr Liriye Kurtovic awarded Moderna Global Fellowship
Research Reports + Policy Briefs
IMPACT Magazine
Events
Research Articles
How Science Matters Podcast
Study at Burnet
Dynamic nucleolar targeting of dengue virus polymerase NS5 in response to extrac...
The HIV response beyond 2030: preparing for decades of sustained HIV epidemic co...
PRECISE pregnancy cohort: challenges and strategies in setting up a biorepositor...
Harnessing the PRECISE network as a platform to strengthen global capacity for m...
Vaccines
Diagnostics
Therapeutics
Antibody Platforms
Australia
Papua New Guinea
Myanmar
People of Burnet
Leadership
Burnet Partners
Board Members
Current Appeal
Monthly Giving
Trusts + Foundations
Corporate Supporters
Giving in Wills + Bequests
Supporter Stories
About Us
Careers
History
Annual + Financial Reports
Explore our research reports and policy briefs, designed to explain key findings of our work clearly and provide recommendations for government, community organisations and policymakers alike.
For peer reviewed publications, see: Research Articles
In 1998, the Australian Research Centre in Sex, Health and Society (ARCSHS) at La Trobe University c...
Abstract Objectives: To assess the risks associated with relaxing coronavirus disease 2019 (COVID-19...
In this study, we use Covasim to estimate the risk of Victoria experiencing a third COVID-19 epidemi...
General practitioners' knowledge of hepatitis C care has increased over time, yet many are unsure wh...
The number of people being cured of hepatitis C has improved since the introduction of direct-acting...
There are currently 11 vaccine candidates for COVID‑19 in clinical trials. Five of the six vaccines ...
Providing hepatitis C treatment in the primary care setting increases both treatment uptake and cure...
Hepatitis C poses a significant public health concern in Australia, with over 170,000 individuals es...
Rapid EC: Point-of-care testing for hepatitis C at needle and syringe programs is feasible and accep...
Young male prisoners with a history of injecting drug use are among the most disadvantaged and vulne...
Universal availability of hepatitis C treatment is a critical but insufficient step towards eliminat...
Implementation of a remote consultation pathway facilitates interaction between general practitioner...
Targeted interventions are needed to increase hepatitis C treatment uptake in non- metropolitan area...
Routine testing and prompt treatment uptake can significantly reduce hepatitis C prevalence among HI...
The Salvation Army commissioned the Burnet Institute to gather data on its 24-hour needle and syring...